Development of novel gastroretentive floating particulate drug delivery system of gliclazide

Current Drug Delivery

Volumn 9, Issue 5, 2012, Pages 437-451

  Awasthi, Rajendra ^a   Kulkarni, Giriraj T ^a  

^a Laureate Institute of Pharmacy Kathog   (India)

Author keywords

Alginate bead; Buoyancy; Floating bead; Gastroretentive; Gliclazide; Glucose tolerance

Indexed keywords

ALGINIC ACID; CALCIUM CARBONATE; GELATIN; GLICLAZIDE; HYDROXYPROPYLMETHYLCELLULOSE; INSULIN; PECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG RELEASE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HYPOGLYCEMIA; IN VITRO STUDY; IN VIVO STUDY; INFRARED SPECTROSCOPY; INSULIN BLOOD LEVEL; LIPID DIET; MALE; MICROPHOTOGRAPHY; MOUSE; NONHUMAN; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STOMACH; X RAY DIFFRACTION;

ALGINATES; ANIMALS; BLOOD GLUCOSE; CALCIUM CARBONATE; DRUG CARRIERS; GASTROINTESTINAL TRACT; GELATIN; GLICLAZIDE; GLUCOSE TOLERANCE TEST; GLUCURONIC ACID; HEXURONIC ACIDS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; METHYLCELLULOSE; MICE; MICE, INBRED C57BL; OBESITY; PARTICLE SIZE; PECTINS;

EID: 84867021182     PISSN: 15672018     EISSN: 18755704     Source Type: Journal    
DOI: 10.2174/156720112802650716     Document Type: Article

References (24)

1. Pawar, V.K.; Kansal, S.; Garg, G.; Awasthi, R.; Singodia, D.; Kulkarni, G.T. Gastroretentive dosage forms: A review with special emphasis on floating drug delivery systems. Drug Deliv., 2011, 18 (2), 97-110.
2. Jain, S.K.; Gupta, A. Development of Gelucire 43/01 Beads of metformin hydrochloride for floating delivery. AAPS Pharm-SciTech., 2009, 10 (4), 1128-1136.
3. Awasthi, R.; Pawar, V.; Kulkarni, G.T. Floating microparticulate systems: An approach to increase gastric retention. Indian J. Pharm., 2010, 1 (1), 17-26.
4. Sriamornsak, P.; Thirawong, N.; Puttipipatkhachorn, S. Morphology and buoyancy of oil-entrapped calcium pectinate gel beads. AAPS J., 2004, 6 (3) Article 24 (http://www.aapsj.org). Accessed on 9.10.2011.
5. Choe, S.Y.; Neudeck, B.L.; Welage, L.S.; Amidon, G.E.; Barnett, J.L.; Amidon, G.L. Novel method to assess gastric emptying in humans: pellet gastric emptying test. Eur. J. Pharm. Sci., 2001, 14, 347-353.
6. Rhie, J.K.; Hayashi, Y.; Welage, L.S.; Frens, J.; Wald, R.J.; Barnett, J.L.; Amidon, G.E.; Putcha, L.; Amidon, G.L. Drug marker absorption in relation pellet size, gastric motility and viscous meals in humans. Pharm. Res., 1998, 15, 233-238.
7. Zhao, Y.; Chen, W.; Cai, Q.; Wang, S.; Bo, J.; Wu, C. Erosion induced controllable release of gliclazide encapsulated inside dgradable polymeric particles. Macromol. Biosci., 2004, 4, 308-313.
8. Awasthi, R.; Kulkarni, G.T.; Pawar, V.K.; Garg, G. Optimization studies on gastroretentive floating system using response surface methodology. AAPS Pharm. Sci. Tech., 2012, 13 (1), 85-93.
9. Pasparakis, G.; Bouropoulos, N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginatechitosan beads. Int. J. Pharm., 2006, 323, 34-42.
10. Sharma, V.K.; Bhattacharya, A. Release of metformin hydrochloride from ispaghula-sodium alginate beads adhered on cock intestinal mucosa. Indian J. Pharm. Educ. Res., 2008, 42, 365-72.
11. George, M.; Abraham, T.E. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosana review. J. Control Rel., 2006, 114, 1-14.
12. Kesavan, K.; Nath, G.; Pandit, J.K. Sodium alginate based mucoadhesive system for gatifloxacin and it's in vitro antibacterial activity. Sci. Pharm., 2010, 78, 941-957.
13. Kroll, E.; Winnik, F.M.; Ziolo, R.F. In situ preparation of nanocrystalline Fe2O3 in iron (II) crosslinked alginate gels. Chem. Mater., 1996, 8, 1594-1596.
14. Llanes, F.; Ryan, D.H.; Marchessault, R.H. Magnetic nanostructured composites using alginates of different M/G ratios as polymeric matrix. Int. J. Biol. Macromol., 2000, 27, 35-40.
15. Liua, L.S.; Fishmana, M.L.; Hicks, K.B.; Kende, M. Interaction of various pectin formulations with porcine colonic tissues. Biomaterials, 2005, 26, 5907-5916.
16. Behall, K.; Reiser, S. ACS Symposium Series, American ChemicalSociety 1986; Vol. 310, pp 248-265.
17. th edition 2009 pp. 326-329.
18. Hong, S.; Lee, S.; Lee, Y.; Chung, S.; Lee, M.; Shim, C. Accelerated oral absorption of gliclazide in human subjects from a soft gelatin capsule containing a PEG 400 suspension of gliclazide. J. Control Rel., 1998, 51, 85-92.
19. Gribic, S.; Parojcic, J.; Ibric, S.; Djuric, Z. In vitroin vivo correlation for gliclazide immediate-release tablets based on mechanistic absorption simulation. AAPS Pharm. Sci. Tech., 2011, 12 (1), 165-171.
20. Al-Kassas, R.S.; Al-Gohary, O.M.N.; Al-Faadhel, M.M. Controlling of systemic absorption of gliclazide through incorporation into alginate beads. Int. J. Pharm., 2007, 341, 230-237.
21. Prajapati, S.K.; Tripathi, P.; Ubaidulla, U.; Anand, V. Design and development of gliclazide mucoadhesive microcapsules: in vitro and in vivo evaluation. AAPS Pharm. Sci. Tech., 2008, 9 (1), 224-30.
22. Guidance for Industry "Dissolution testing of immediate release solid oral dosage forms" U.S. Department of Health and Human Services, Center for Drug Evaluation and Research (CDER), August 1997.
23. Hamza, N.; Berke, B.; Cheze, C.; Agli, A.N.; Robinson, P.; Gin, H.; Moore N. Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria. J. Ethnopharmacol., 2010, 128, 513-518.
24. Costa, P.; Lobo, J.M.S. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci., 2001, 13, 123-133.